Harbor Capital Advisors’s Alnylam Pharmaceuticals ALNY Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Change in Stake | Trade Value | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2026
Q1 | $564K | Buy |
|
|||||
|
2025
Q1 | – | Sell |
|
|||||
|
2024
Q4 | $624K | Buy |
|
|||||
|
2024
Q3 | $712K | Buy |
|
|||||
|
2024
Q2 | $626K | Buy |
|
|||||
|
2024
Q1 | $384K | Sell |
|
|||||
|
2023
Q4 | $562K | Buy |
|
|||||
|
2023
Q3 | $511K | Buy |
|
|||||
|
2023
Q2 | $517K | Sell |
|
|||||
|
2023
Q1 | $548K | Buy |
|
|||||
|
2022
Q4 | $89.1K | Sell |
|
|||||
|
2022
Q3 | $79K | Sell |
|
|||||
|
2022
Q2 | $176K | Buy |
|
|||||
|
2022
Q1 | $180K | Buy |
|